Last 22 quarters of trend data · Healthcare · Medical - Pharmaceuticals
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.40 | — | — | — | — | — | — | — | — | — | — | 1.15 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 365.56 | 210.15 | 213.01 | 384.22 | 149.68 | 38.54 | — | 1164.51 | 195.34 | — | 3110.68 | 577.51 | 389.48 |
| — | +445.3% | — | -67.0% | -23.4% | — | — | +101.6% | -49.8% | — | +12.0% | -89.3% | -52.7% | |
| P/B Ratio | 4.14 | 4.03 | 4.09 | 7.20 | 2.99 | 1.57 | 1.83 | 1.27 | 1.27 | 1.40 | 0.92 | 0.75 | 1.24 |
| — | +156.3% | +123.9% | +465.3% | +136.3% | +12.3% | +99.4% | +70.1% | +1.9% | +19.6% | -42.3% | -57.2% | -29.0% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Atai Beckley N.V's operating margin was -3239.1% in Q1 2026, up 793.0 pp QoQ and down 1929.1 pp YoY. The trailing four-quarter average of -3645.7% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 4.2% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.3% | 82.5% | 100.0% | 68.9% | 68.4% | 86.1% | 100.0% | -107.5% | 70.0% | — | -461.1% | 14.9% | -13.4% |
| — | -4.2% | 0.0% | +164.1% | -2.2% | — | +121.7% | -819.4% | +623.2% | — | -1068.1% | +129.9% | -115.1% | |
| Operating Margin | -2439.7% | -3239.1% | -4032.1% | -3796.5% | -3515.0% | -1310.0% | 605300.0% | -56505.0% | -9424.5% | — | -186450.0% | -30843.7% | -18524.4% |
| — | -147.3% | -100.7% | +93.3% | +62.7% | — | +424.6% | -83.2% | +49.1% | — | -88.6% | +80.7% | +10.0% | |
| Net Margin | -16142.0% | -3121.8% | -51108.2% | -8154.1% | -3856.6% | -1699.7% | 779160.0% | -65715.0% | -20993.4% | — | -101622.2% | 50855.2% | -19210.5% |
| — | -83.7% | -106.6% | +87.6% | +81.6% | — | +866.7% | -229.2% | -9.3% | — | +14.2% | +136.0% | +10.8% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -389.9% | -14.2% | -285.3% | -40.2% | -18.7% | -19.7% | -29.6% | -16.7% | -29.3% | -11.4% | -7.1% | 18.3% | -14.5% |
| — | +28.0% | -862.6% | -140.8% | +36.0% | -72.1% | -315.5% | -191.4% | -102.0% | +12.7% | +55.5% | +266.2% | -33.4% | |
| ROA | -280.9% | -10.4% | -198.0% | -28.5% | -14.4% | -14.9% | -21.8% | -12.7% | -23.6% | -9.5% | -6.1% | 15.8% | -12.4% |
| — | +30.5% | -806.9% | -123.8% | +39.1% | -56.7% | -259.1% | -180.8% | -91.1% | +16.0% | +56.2% | +260.7% | -23.7% | |
| ROIC | -57.0% | -15.6% | -23.8% | -19.1% | -17.1% | -12.0% | -17.2% | -11.0% | -9.8% | -8.1% | -11.8% | -13.4% | -29.4% |
| — | -30.2% | -38.2% | -73.8% | -74.5% | -48.1% | -45.9% | +18.2% | +66.7% | +73.6% | +45.9% | +5.7% | -161.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 146.2% YoY to 10.02x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | 0.18 | 0.21 | 0.16 | 0.12 | 0.09 | 0.08 | 0.06 | 0.08 |
| — | -94.3% | -95.6% | -88.6% | -45.0% | +87.9% | +170.5% | +162.1% | +50.4% | +34.2% | +37.7% | +22.5% | +3905.6% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 11.74 | 10.02 | 11.74 | 7.90 | 4.02 | 4.07 | 3.21 | 5.81 | 6.68 | 7.83 | 9.22 | 10.96 | 13.54 |
| — | +146.2% | +265.6% | +36.0% | -39.9% | -48.0% | -65.2% | -47.0% | -50.7% | -41.7% | -36.1% | -10.6% | -8.1% | |
| Quick Ratio | 11.74 | 10.02 | 11.74 | 7.90 | 4.02 | 4.07 | 3.21 | 5.81 | 6.68 | 7.83 | 9.22 | 10.96 | 13.54 |
| — | +146.2% | +265.6% | +36.0% | -39.9% | -48.0% | -65.2% | -47.0% | -50.7% | -41.7% | -36.1% | -8.6% | -7.0% | |
| Interest Coverage | -85.85 | — | — | — | -95.73 | -22.63 | -30.83 | -28.87 | -36.65 | -34.91 | -48.57 | -39.12 | -48.42 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 22 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ATAI stock.
Atai Beckley N.V's current P/E is -1.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Atai Beckley N.V's current operating margin is -2439.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Atai Beckley N.V's business trajectory between earnings reports.